The new 4DMedical post Imbio integration will be a beefed up lung and heart diagnostic company with a large platform of diagnostic products for customers to choose from.
What this means commercially is that our selling points into new customers is much more compelling.
Take screening programs in Australia and USA and using the lung cancer screening program to begin by mid 2025. With our existing relationship with govt, academic and industry, if we tendered to help out for this (assume if 4DX pointed out in their presentation, they are looking closely at it whilst the govt is setting this program up), we would be in strong running to provide our products for this purpose. The VA and DID would also see more compelling reasons to adopt our products too.
Just a couple examples, but even for new agreements we would pitch for with US radiology clinics, it's definitely a more compelling selling point - as if Medicare reimbursement wasn't enough.
Ann: Investor Presentation Imbio acquisition and capital raise, page-28
-
- There are more pages in this discussion • 64 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add 4DX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
53.0¢ |
Change
-0.015(2.75%) |
Mkt cap ! $217.5M | |||
| Open | High | Low | Value | Volume |
| 55.0¢ | 55.5¢ | 51.5¢ | $216.4K | 408.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 58983 | 53.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 56.5¢ | 3571 | 1 |
View Market Depth
| Last trade - 16.10pm 05/07/2024 (20 minute delay) ? |
| 4DX (ASX) Chart |